HEADER MEMBRANE PROTEIN 11-JAN-21 7LCK TITLE PF 06882961 BOUND TO THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR (GLP-1R) COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCAGON-LIKE PEPTIDE 1 RECEPTOR; COMPND 3 CHAIN: R; COMPND 4 SYNONYM: GLP-1R; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GLP1R; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS GPCR, SMALL MOLECULE AGONIST, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR M.J.BELOUSOFF,R.M.JOHNSON,I.DRULYTE,L.YU,A.KOTECHA,R.DANEV,D.WOOTTEN, AUTHOR 2 X.ZHANG,P.M.SEXTON REVDAT 3 15-SEP-21 7LCK 1 JRNL REVDAT 2 19-MAY-21 7LCK 1 JRNL REVDAT 1 20-JAN-21 7LCK 0 JRNL AUTH X.ZHANG,R.M.JOHNSON,I.DRULYTE,L.YU,A.KOTECHA,R.DANEV, JRNL AUTH 2 D.WOOTTEN,P.M.SEXTON,M.J.BELOUSOFF JRNL TITL EVOLVING CRYO-EM STRUCTURAL APPROACHES FOR GPCR DRUG JRNL TITL 2 DISCOVERY. JRNL REF STRUCTURE V. 29 963 2021 JRNL REFN ISSN 0969-2126 JRNL PMID 33957078 JRNL DOI 10.1016/J.STR.2021.04.008 REMARK 2 REMARK 2 RESOLUTION. 3.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.240 REMARK 3 NUMBER OF PARTICLES : 632000 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7LCK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1000254078. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : GLP-1:GS COMPLEX WITH SMALL REMARK 245 MOLECULE AGONIST (PF-06882961) REMARK 245 BOUND REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 5.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS GLACIOS REMARK 245 DETECTOR TYPE : FEI FALCON IV (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5580.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 200 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: R REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET R -8 REMARK 465 LYS R -7 REMARK 465 THR R -6 REMARK 465 ILE R -5 REMARK 465 ILE R -4 REMARK 465 ALA R -3 REMARK 465 LEU R -2 REMARK 465 SER R -1 REMARK 465 TYR R 0 REMARK 465 ILE R 1 REMARK 465 PHE R 2 REMARK 465 CYS R 3 REMARK 465 LEU R 4 REMARK 465 VAL R 5 REMARK 465 PHE R 6 REMARK 465 ALA R 7 REMARK 465 ASP R 8 REMARK 465 TYR R 9 REMARK 465 LYS R 10 REMARK 465 ASP R 11 REMARK 465 ASP R 12 REMARK 465 ASP R 13 REMARK 465 ASP R 14 REMARK 465 LEU R 15 REMARK 465 GLU R 16 REMARK 465 VAL R 17 REMARK 465 LEU R 18 REMARK 465 PHE R 19 REMARK 465 GLN R 20 REMARK 465 GLY R 21 REMARK 465 PRO R 22 REMARK 465 ALA R 23 REMARK 465 ARG R 24 REMARK 465 PRO R 25 REMARK 465 GLN R 26 REMARK 465 GLY R 27 REMARK 465 SER R 129 REMARK 465 LYS R 130 REMARK 465 ARG R 131 REMARK 465 GLY R 132 REMARK 465 GLU R 133 REMARK 465 ARG R 134 REMARK 465 HIS R 424 REMARK 465 LEU R 425 REMARK 465 HIS R 426 REMARK 465 ILE R 427 REMARK 465 GLN R 428 REMARK 465 ARG R 429 REMARK 465 ASP R 430 REMARK 465 SER R 431 REMARK 465 SER R 432 REMARK 465 MET R 433 REMARK 465 LYS R 434 REMARK 465 PRO R 435 REMARK 465 LEU R 436 REMARK 465 LYS R 437 REMARK 465 CYS R 438 REMARK 465 PRO R 439 REMARK 465 THR R 440 REMARK 465 SER R 441 REMARK 465 SER R 442 REMARK 465 LEU R 443 REMARK 465 SER R 444 REMARK 465 SER R 445 REMARK 465 GLY R 446 REMARK 465 ALA R 447 REMARK 465 THR R 448 REMARK 465 ALA R 449 REMARK 465 GLY R 450 REMARK 465 SER R 451 REMARK 465 SER R 452 REMARK 465 MET R 453 REMARK 465 TYR R 454 REMARK 465 THR R 455 REMARK 465 ALA R 456 REMARK 465 THR R 457 REMARK 465 CYS R 458 REMARK 465 GLN R 459 REMARK 465 ALA R 460 REMARK 465 SER R 461 REMARK 465 CYS R 462 REMARK 465 SER R 463 REMARK 465 PRO R 464 REMARK 465 ALA R 465 REMARK 465 GLY R 466 REMARK 465 LEU R 467 REMARK 465 GLU R 468 REMARK 465 VAL R 469 REMARK 465 LEU R 470 REMARK 465 PHE R 471 REMARK 465 GLN R 472 REMARK 465 GLY R 473 REMARK 465 PRO R 474 REMARK 465 HIS R 475 REMARK 465 HIS R 476 REMARK 465 HIS R 477 REMARK 465 HIS R 478 REMARK 465 HIS R 479 REMARK 465 HIS R 480 REMARK 465 HIS R 481 REMARK 465 HIS R 482 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN R 338 CG OD1 ND2 REMARK 470 LEU R 339 CG CD1 CD2 REMARK 470 MET R 340 CG SD CE REMARK 470 CYS R 341 SG REMARK 470 LYS R 342 CG CD CE NZ REMARK 470 THR R 343 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN R 112 O SER R 117 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU R 68 -4.15 72.38 REMARK 500 PRO R 96 41.30 -85.35 REMARK 500 SER R 117 -168.61 -118.69 REMARK 500 LEU R 172 62.76 -102.43 REMARK 500 CYS R 174 -168.05 -103.13 REMARK 500 SER R 206 31.37 -95.89 REMARK 500 PHE R 257 60.68 63.32 REMARK 500 CYS R 403 -13.73 -140.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6X1A RELATED DB: PDB REMARK 900 RELATED ID: 7LCI RELATED DB: PDB REMARK 900 SAME STUDY REMARK 900 RELATED ID: 7LCJ RELATED DB: PDB REMARK 900 SAME STUDY REMARK 900 RELATED ID: EMD-23276 RELATED DB: EMDB REMARK 900 PF 06882961 BOUND TO THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR (GLP-1R) DBREF 7LCK R 24 463 UNP P43220 GLP1R_HUMAN 24 463 SEQADV 7LCK MET R -8 UNP P43220 EXPRESSION TAG SEQADV 7LCK LYS R -7 UNP P43220 EXPRESSION TAG SEQADV 7LCK THR R -6 UNP P43220 EXPRESSION TAG SEQADV 7LCK ILE R -5 UNP P43220 EXPRESSION TAG SEQADV 7LCK ILE R -4 UNP P43220 EXPRESSION TAG SEQADV 7LCK ALA R -3 UNP P43220 EXPRESSION TAG SEQADV 7LCK LEU R -2 UNP P43220 EXPRESSION TAG SEQADV 7LCK SER R -1 UNP P43220 EXPRESSION TAG SEQADV 7LCK TYR R 0 UNP P43220 EXPRESSION TAG SEQADV 7LCK ILE R 1 UNP P43220 EXPRESSION TAG SEQADV 7LCK PHE R 2 UNP P43220 EXPRESSION TAG SEQADV 7LCK CYS R 3 UNP P43220 EXPRESSION TAG SEQADV 7LCK LEU R 4 UNP P43220 EXPRESSION TAG SEQADV 7LCK VAL R 5 UNP P43220 EXPRESSION TAG SEQADV 7LCK PHE R 6 UNP P43220 EXPRESSION TAG SEQADV 7LCK ALA R 7 UNP P43220 EXPRESSION TAG SEQADV 7LCK ASP R 8 UNP P43220 EXPRESSION TAG SEQADV 7LCK TYR R 9 UNP P43220 EXPRESSION TAG SEQADV 7LCK LYS R 10 UNP P43220 EXPRESSION TAG SEQADV 7LCK ASP R 11 UNP P43220 EXPRESSION TAG SEQADV 7LCK ASP R 12 UNP P43220 EXPRESSION TAG SEQADV 7LCK ASP R 13 UNP P43220 EXPRESSION TAG SEQADV 7LCK ASP R 14 UNP P43220 EXPRESSION TAG SEQADV 7LCK LEU R 15 UNP P43220 EXPRESSION TAG SEQADV 7LCK GLU R 16 UNP P43220 EXPRESSION TAG SEQADV 7LCK VAL R 17 UNP P43220 EXPRESSION TAG SEQADV 7LCK LEU R 18 UNP P43220 EXPRESSION TAG SEQADV 7LCK PHE R 19 UNP P43220 EXPRESSION TAG SEQADV 7LCK GLN R 20 UNP P43220 EXPRESSION TAG SEQADV 7LCK GLY R 21 UNP P43220 EXPRESSION TAG SEQADV 7LCK PRO R 22 UNP P43220 EXPRESSION TAG SEQADV 7LCK ALA R 23 UNP P43220 EXPRESSION TAG SEQADV 7LCK PHE R 260 UNP P43220 LEU 260 CONFLICT SEQADV 7LCK PRO R 464 UNP P43220 EXPRESSION TAG SEQADV 7LCK ALA R 465 UNP P43220 EXPRESSION TAG SEQADV 7LCK GLY R 466 UNP P43220 EXPRESSION TAG SEQADV 7LCK LEU R 467 UNP P43220 EXPRESSION TAG SEQADV 7LCK GLU R 468 UNP P43220 EXPRESSION TAG SEQADV 7LCK VAL R 469 UNP P43220 EXPRESSION TAG SEQADV 7LCK LEU R 470 UNP P43220 EXPRESSION TAG SEQADV 7LCK PHE R 471 UNP P43220 EXPRESSION TAG SEQADV 7LCK GLN R 472 UNP P43220 EXPRESSION TAG SEQADV 7LCK GLY R 473 UNP P43220 EXPRESSION TAG SEQADV 7LCK PRO R 474 UNP P43220 EXPRESSION TAG SEQADV 7LCK HIS R 475 UNP P43220 EXPRESSION TAG SEQADV 7LCK HIS R 476 UNP P43220 EXPRESSION TAG SEQADV 7LCK HIS R 477 UNP P43220 EXPRESSION TAG SEQADV 7LCK HIS R 478 UNP P43220 EXPRESSION TAG SEQADV 7LCK HIS R 479 UNP P43220 EXPRESSION TAG SEQADV 7LCK HIS R 480 UNP P43220 EXPRESSION TAG SEQADV 7LCK HIS R 481 UNP P43220 EXPRESSION TAG SEQADV 7LCK HIS R 482 UNP P43220 EXPRESSION TAG SEQRES 1 R 491 MET LYS THR ILE ILE ALA LEU SER TYR ILE PHE CYS LEU SEQRES 2 R 491 VAL PHE ALA ASP TYR LYS ASP ASP ASP ASP LEU GLU VAL SEQRES 3 R 491 LEU PHE GLN GLY PRO ALA ARG PRO GLN GLY ALA THR VAL SEQRES 4 R 491 SER LEU TRP GLU THR VAL GLN LYS TRP ARG GLU TYR ARG SEQRES 5 R 491 ARG GLN CYS GLN ARG SER LEU THR GLU ASP PRO PRO PRO SEQRES 6 R 491 ALA THR ASP LEU PHE CYS ASN ARG THR PHE ASP GLU TYR SEQRES 7 R 491 ALA CYS TRP PRO ASP GLY GLU PRO GLY SER PHE VAL ASN SEQRES 8 R 491 VAL SER CYS PRO TRP TYR LEU PRO TRP ALA SER SER VAL SEQRES 9 R 491 PRO GLN GLY HIS VAL TYR ARG PHE CYS THR ALA GLU GLY SEQRES 10 R 491 LEU TRP LEU GLN LYS ASP ASN SER SER LEU PRO TRP ARG SEQRES 11 R 491 ASP LEU SER GLU CYS GLU GLU SER LYS ARG GLY GLU ARG SEQRES 12 R 491 SER SER PRO GLU GLU GLN LEU LEU PHE LEU TYR ILE ILE SEQRES 13 R 491 TYR THR VAL GLY TYR ALA LEU SER PHE SER ALA LEU VAL SEQRES 14 R 491 ILE ALA SER ALA ILE LEU LEU GLY PHE ARG HIS LEU HIS SEQRES 15 R 491 CYS THR ARG ASN TYR ILE HIS LEU ASN LEU PHE ALA SER SEQRES 16 R 491 PHE ILE LEU ARG ALA LEU SER VAL PHE ILE LYS ASP ALA SEQRES 17 R 491 ALA LEU LYS TRP MET TYR SER THR ALA ALA GLN GLN HIS SEQRES 18 R 491 GLN TRP ASP GLY LEU LEU SER TYR GLN ASP SER LEU SER SEQRES 19 R 491 CYS ARG LEU VAL PHE LEU LEU MET GLN TYR CYS VAL ALA SEQRES 20 R 491 ALA ASN TYR TYR TRP LEU LEU VAL GLU GLY VAL TYR LEU SEQRES 21 R 491 TYR THR LEU LEU ALA PHE SER VAL PHE SER GLU GLN TRP SEQRES 22 R 491 ILE PHE ARG LEU TYR VAL SER ILE GLY TRP GLY VAL PRO SEQRES 23 R 491 LEU LEU PHE VAL VAL PRO TRP GLY ILE VAL LYS TYR LEU SEQRES 24 R 491 TYR GLU ASP GLU GLY CYS TRP THR ARG ASN SER ASN MET SEQRES 25 R 491 ASN TYR TRP LEU ILE ILE ARG LEU PRO ILE LEU PHE ALA SEQRES 26 R 491 ILE GLY VAL ASN PHE LEU ILE PHE VAL ARG VAL ILE CYS SEQRES 27 R 491 ILE VAL VAL SER LYS LEU LYS ALA ASN LEU MET CYS LYS SEQRES 28 R 491 THR ASP ILE LYS CYS ARG LEU ALA LYS SER THR LEU THR SEQRES 29 R 491 LEU ILE PRO LEU LEU GLY THR HIS GLU VAL ILE PHE ALA SEQRES 30 R 491 PHE VAL MET ASP GLU HIS ALA ARG GLY THR LEU ARG PHE SEQRES 31 R 491 ILE LYS LEU PHE THR GLU LEU SER PHE THR SER PHE GLN SEQRES 32 R 491 GLY LEU MET VAL ALA ILE LEU TYR CYS PHE VAL ASN ASN SEQRES 33 R 491 GLU VAL GLN LEU GLU PHE ARG LYS SER TRP GLU ARG TRP SEQRES 34 R 491 ARG LEU GLU HIS LEU HIS ILE GLN ARG ASP SER SER MET SEQRES 35 R 491 LYS PRO LEU LYS CYS PRO THR SER SER LEU SER SER GLY SEQRES 36 R 491 ALA THR ALA GLY SER SER MET TYR THR ALA THR CYS GLN SEQRES 37 R 491 ALA SER CYS SER PRO ALA GLY LEU GLU VAL LEU PHE GLN SEQRES 38 R 491 GLY PRO HIS HIS HIS HIS HIS HIS HIS HIS HET UK4 R 501 41 HETNAM UK4 2-[(4-{6-[(4-CYANO-2-FLUOROPHENYL)METHOXY]PYRIDIN-2- HETNAM 2 UK4 YL}PIPERIDIN-1-YL)METHYL]-1-{[(2S)-OXETAN-2- HETNAM 3 UK4 YL]METHYL}-1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID FORMUL 2 UK4 C31 H30 F N5 O4 FORMUL 3 HOH *11(H2 O) HELIX 1 AA1 SER R 31 ASP R 53 1 23 HELIX 2 AA2 SER R 136 PHE R 169 1 34 HELIX 3 AA3 THR R 175 LEU R 201 1 27 HELIX 4 AA4 GLN R 210 HIS R 212 5 3 HELIX 5 AA5 GLN R 213 ASP R 222 1 10 HELIX 6 AA6 LEU R 224 ALA R 256 1 33 HELIX 7 AA7 SER R 261 VAL R 276 1 16 HELIX 8 AA8 PRO R 277 LEU R 279 5 3 HELIX 9 AA9 PHE R 280 GLU R 292 1 13 HELIX 10 AB1 TRP R 306 ALA R 337 1 32 HELIX 11 AB2 CYS R 341 GLY R 361 1 21 HELIX 12 AB3 HIS R 363 VAL R 370 1 8 HELIX 13 AB4 GLY R 377 THR R 391 1 15 HELIX 14 AB5 PHE R 393 TYR R 402 1 10 HELIX 15 AB6 ASN R 406 ARG R 421 1 16 SHEET 1 AA1 2 THR R 65 PHE R 66 0 SHEET 2 AA1 2 CYS R 71 TRP R 72 -1 O TRP R 72 N THR R 65 SHEET 1 AA2 3 PHE R 80 SER R 84 0 SHEET 2 AA2 3 HIS R 99 THR R 105 -1 O ARG R 102 N VAL R 81 SHEET 3 AA2 3 LEU R 109 TRP R 110 -1 O LEU R 109 N THR R 105 SHEET 1 AA3 3 PHE R 80 SER R 84 0 SHEET 2 AA3 3 HIS R 99 THR R 105 -1 O ARG R 102 N VAL R 81 SHEET 3 AA3 3 ARG R 121 ASP R 122 -1 O ASP R 122 N TYR R 101 SSBOND 1 CYS R 46 CYS R 71 1555 1555 2.04 SSBOND 2 CYS R 62 CYS R 104 1555 1555 2.04 SSBOND 3 CYS R 85 CYS R 126 1555 1555 2.03 SSBOND 4 CYS R 226 CYS R 296 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000